Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy
Background: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Sci...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354624001972 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832586237718822912 |
---|---|
author | Marialuisa Appetecchia Carlotta Amantea Marco Canfora Fabrizio Petrone Gennaro Ciliberto Ermete Gallo Laura Figorilli |
author_facet | Marialuisa Appetecchia Carlotta Amantea Marco Canfora Fabrizio Petrone Gennaro Ciliberto Ermete Gallo Laura Figorilli |
author_sort | Marialuisa Appetecchia |
collection | DOAJ |
description | Background: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Scientifico Istituti Fisioterapici Ospitalieri) in Rome. The object of investigation is the disease management team (DMT) organization for the diagnosis and treatment of people suffering from oncological disease and the consequences in terms of improving their management. Methods: The study focuses, in particular, on the analysis of the different organizational methods chosen for the management of activities related to diagnosis and treatment paths. Results: The results, although preliminary, highlight a great variability in the adoption of integrated organizational models by the different DMTs compatible with the heterogeneity of oncological diseases. Conclusion: The results of this study have highlighted that, despite the diversity of the different DMTs created for different oncological pathologies, DMTs guarantee a patient-centered approach and the creation of shared databases, which facilitates the evaluation of progress and the identification of areas for improvement. This analysis has allowed us to obtain a useful map of the models used by the different DMTs, also laying the foundations for more precise evaluations of their effectiveness. The correct evaluation of the effectiveness of DMTs acquires great importance today, especially if we consider that empirical evidence is not yet in agreement on the real effectiveness of this tool with respect to both the qualitative dimension and the efficiency of interventions. |
format | Article |
id | doaj-art-f969fbfe7f994c6f93e2d50fe1ece74d |
institution | Kabale University |
issn | 2666-3546 |
language | English |
publishDate | 2025-02-01 |
publisher | Elsevier |
record_format | Article |
series | Brain, Behavior, & Immunity - Health |
spelling | doaj-art-f969fbfe7f994c6f93e2d50fe1ece74d2025-01-26T05:05:00ZengElsevierBrain, Behavior, & Immunity - Health2666-35462025-02-0143100919Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, ItalyMarialuisa Appetecchia0Carlotta Amantea1Marco Canfora2Fabrizio Petrone3Gennaro Ciliberto4Ermete Gallo5Laura Figorilli6Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Italy; Corresponding author. Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Italy.Department of Health Science and Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, ItalyScientific Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyNursing, Technical, Rehabilitation, Assistance and Research Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyScientific Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyCorporate Health Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyGeneral Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, ItalyBackground: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Scientifico Istituti Fisioterapici Ospitalieri) in Rome. The object of investigation is the disease management team (DMT) organization for the diagnosis and treatment of people suffering from oncological disease and the consequences in terms of improving their management. Methods: The study focuses, in particular, on the analysis of the different organizational methods chosen for the management of activities related to diagnosis and treatment paths. Results: The results, although preliminary, highlight a great variability in the adoption of integrated organizational models by the different DMTs compatible with the heterogeneity of oncological diseases. Conclusion: The results of this study have highlighted that, despite the diversity of the different DMTs created for different oncological pathologies, DMTs guarantee a patient-centered approach and the creation of shared databases, which facilitates the evaluation of progress and the identification of areas for improvement. This analysis has allowed us to obtain a useful map of the models used by the different DMTs, also laying the foundations for more precise evaluations of their effectiveness. The correct evaluation of the effectiveness of DMTs acquires great importance today, especially if we consider that empirical evidence is not yet in agreement on the real effectiveness of this tool with respect to both the qualitative dimension and the efficiency of interventions.http://www.sciencedirect.com/science/article/pii/S2666354624001972Disease management teamOncological diseasesHealthcare organization |
spellingShingle | Marialuisa Appetecchia Carlotta Amantea Marco Canfora Fabrizio Petrone Gennaro Ciliberto Ermete Gallo Laura Figorilli Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy Brain, Behavior, & Immunity - Health Disease management team Oncological diseases Healthcare organization |
title | Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy |
title_full | Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy |
title_fullStr | Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy |
title_full_unstemmed | Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy |
title_short | Disease management teams in oncology: State of the art and the experience of a scientific institute of hospitalization and treatment (IRCCS) in Rome, Italy |
title_sort | disease management teams in oncology state of the art and the experience of a scientific institute of hospitalization and treatment irccs in rome italy |
topic | Disease management team Oncological diseases Healthcare organization |
url | http://www.sciencedirect.com/science/article/pii/S2666354624001972 |
work_keys_str_mv | AT marialuisaappetecchia diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly AT carlottaamantea diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly AT marcocanfora diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly AT fabriziopetrone diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly AT gennarociliberto diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly AT ermetegallo diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly AT laurafigorilli diseasemanagementteamsinoncologystateoftheartandtheexperienceofascientificinstituteofhospitalizationandtreatmentirccsinromeitaly |